{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:04Z","timestamp":1786119604759,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"s4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.2310\/6350.2005.31237","type":"journal-article","created":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T08:23:33Z","timestamp":1286267013000},"page":"1519-1529","source":"Crossref","is-referenced-by-count":47,"title":["HIV Facial Lipoatrophy"],"prefix":"10.1097","volume":"31","author":[{"given":"Derek","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20231117","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV\u2010associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichentenstein","year":"2001","journal-title":"AIDS"},{"key":"R3-7-20231117","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV\u20101 infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"R4-7-20231117","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside\u2010analog reverse\u2010transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral\u2010therapy\u2010related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R5-7-20231117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy. a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"R6-7-20231117","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection","volume":"10","author":"Collins","year":"2000","journal-title":"AIDS Reader"},{"key":"R7-7-20231117","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","article-title":"Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes","volume":"133","author":"Arioglu","year":"2000","journal-title":"Ann Intern Med"},{"key":"R9-7-20231117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improved insulin sensitivity and body fat distribution in HIV\u2010infected patients treated with rosiglitazone. a pilot study","volume":"31","author":"Gelato","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-7-20231117","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1258\/0956462981921080","article-title":"O'Mahony C, Price LM, Nelson M. Lipodystrophy despite anabolic steroids","volume":"9","author":"O'Mahony","year":"1998","journal-title":"Int J STDs AIDS"},{"key":"R11-7-20231117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engleson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-7-20231117","first-page":"979","article-title":"James J, Carruthers A, Carruthers J. HIV\u2010associated facial lipoatrophy","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"},{"key":"R15-7-20231117","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1524-4725.1999.99118.x","article-title":"Burres S. Preserved particulate fascia lata for injection. a new alternative","volume":"25","author":"Burres","year":"1999","journal-title":"Dermatol Surg"},{"key":"R17-7-20231117","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0294-1260(02)00176-0","article-title":"Caye N, Le Fourn B, Pannier M. Surgical treatment of facial lipoatrophy","volume":"48","author":"Caye","year":"2003","journal-title":"Ann Chir Plast Esthet"},{"key":"R18-7-20231117","first-page":"34","article-title":"Sherman R. Autologous fat transfer for HIV lipodystrophy","volume":"16","author":"Sherman","year":"2003","journal-title":"Cosmet Dermatol"},{"key":"R19-7-20231117","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.PRS.0000128427.54445.63","article-title":"Serra\u2010Renom JM, Fontdevila J. Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection","volume":"114","author":"Serra\u2010Renom","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R20-7-20231117","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open label study of immediate vs. delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"key":"R23-7-20231117","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (NewFill\u00ae) to correct facial lipoatrophy in HIV\u2010infected patients. results of the open\u2010label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R24-7-20231117","first-page":"588","article-title":"A randomized, double\u2010blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds","volume":"29","author":"Narins","year":"2003","journal-title":"Dermatol Surg"},{"key":"R25-7-20231117","first-page":"3826","article-title":"Walther RA. Facial lipodystrophy in patients with HIV is troublesome to treat","volume":"99","author":"Walther","year":"2002","journal-title":"Lakartidningen"},{"key":"R26-7-20231117","first-page":"1276","article-title":"Highly purified 1000 centistoke oil for treatment of HIV\u2010associated facial lipoatrophy","volume":"30","author":"Jones","year":"2004","journal-title":"Dermatol Surg"},{"key":"R28-7-20231117","first-page":"792","article-title":"Brody H. Complications of expanded polytetrafluoroethylene (e\u2010PTFE) facial implant","volume":"27","author":"Brody","year":"2001","journal-title":"Dermatol Surg"},{"key":"R31-7-20231117","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archfaci.6.3.204","article-title":"Severe granulomatous inflammatory response induced by injection of polyacrylamide gel into the facial tissue","volume":"6","author":"de Bree","year":"2004","journal-title":"Arch Facial Plast Surg"},{"key":"R32-7-20231117","first-page":"79","article-title":"Huo M, Huang J, Qi K. Toxicities of polyacrylamide gel implants","volume":"18","author":"Huo","year":"2002","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"R33-7-20231117","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00006534-200301000-00092","article-title":"Bio\u2010Alcamid, a novel prosthetic polymer, does not interfere with morphological and functional characteristics of human skin fibroblasts","volume":"111","author":"Pacini","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R34-7-20231117","first-page":"209","article-title":"Bio\u2010Alcamid. a novelty for reconstructive and cosmetic surgery","volume":"107","author":"Pacini","year":"2002","journal-title":"Ital J Anat Embryol"},{"key":"R35-7-20231117","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/14764170310021922","article-title":"Protopapa C, Giuseppe S, Caporale D, Cammarota N. Bio\u2010Alcamid\u2122 in drug\u2010induced lipodystrophy","volume":"5","author":"Protopapa","year":"2003","journal-title":"J Cosmet Laser Ther"},{"key":"R36-7-20231117","first-page":"764","article-title":"Sklar J, White S. Radiance FN. A new soft tissue filler","volume":"30","author":"Sklar","year":"2004","journal-title":"Dermatol Surg"},{"key":"R37-7-20231117","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archfaci.6.6.394","article-title":"Binder W, Bloom DC. The use of custom\u2010designed midfacial and submalar implants in the treatment of facial wasting syndrome","volume":"6","author":"Binder","year":"2004","journal-title":"Arch Facial Plastic Surg"},{"key":"R38-7-20231117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.PRS.0000097288.27152.38","article-title":"Berish S, Baum T, Robbins N. Treatment of human immunodeficiency virus\u2010associated lipodystrophy with dermafat graft transfer to the malar area","volume":"113","author":"Berish","year":"2004","journal-title":"Plast Reconstr Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-200510004-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:02Z","timestamp":1786041482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200510004-00007"}},"subtitle":["Causes and Treatment Options"],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":28,"journal-issue":{"issue":"s4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2310\/6350.2005.31237","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}